Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
Open Access
- 15 January 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Neurology
- Vol. 14 (1), 12
- https://doi.org/10.1186/1471-2377-14-12
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Amyloid-β Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid AngiopathyStroke, 2012
- Amyloid Beta Induces Oxidative Stress-Mediated Blood–Brain Barrier Changes in Capillary Amyloid AngiopathyAntioxidants and Redox Signaling, 2011
- Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's diseaseJournal of Neuroinflammation, 2011
- Neurovascular mechanisms of Alzheimer's neurodegenerationTrends in Neurosciences, 2005
- Clearance of Alzheimer's Aβ Peptide: The Many Roads to PerditionNeuron, 2004
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimerʼs DiseaseAlzheimer Disease & Associated Disorders, 1997
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975